Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.

Saved in:
Bibliographic Details
Title: Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
Authors: Takeda K; Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan. ktakeda@juntendo.ac.jp.; Department of Biofunctional Micribiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan. ktakeda@juntendo.ac.jp.; Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan. ktakeda@juntendo.ac.jp.; Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, 3002, Victoria, Australia. ktakeda@juntendo.ac.jp., Nakayama M; Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, Sendai, 980-8578, Japan.; Department of Immunobiology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, 980-8575, Japan., Hayakawa Y; Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, 3002, Victoria, Australia.; Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Sugitani 2630, Toyama, 930-0194, Japan., Kojima Y; Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan., Ikeda H; Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.; Department of Oncology, Nagasaki University Graduate School of Biomedical Science, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan., Imai N; Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.; Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, 1470 Madison Avenue, New York, New York, 10029, USA., Ogasawara K; Department of Immunobiology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, 980-8575, Japan., Okumura K; Department of Biofunctional Micribiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan.; Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan.; Atopy (Allergy) Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan., Thomas DM; Cancer Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010, Australia., Smyth MJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, 3002, Victoria, Australia.; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia.; School of Medicine, University of Queensland, Herston, 4006, Queensland, Australia.
Source: Nature communications [Nat Commun] 2024 Dec 04; Vol. 15 (1), pp. 10558. Date of Electronic Publication: 2024 Dec 04.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-024-53456-2